A Lupus-Associated Mac-1 Variant Has Defects in Integrin Allostery and Interaction with Ligands under Force  by Rosetti, Florencia et al.
ReportA Lupus-Associated Mac-1 Variant Has Defects in
Integrin Allostery and Interaction with Ligands under
ForceGraphical AbstractHighlightsd The lupus risk SNP, R77H, impairs Mac-1 affinity for ligand
d R77H inhibits force-induced allosteric relay, prolonging Mac-
1/ligand bond lifetime
d The b-propeller domain contributes to the relay of allostery in
Mac-1
d Defects in R77H are rescued by integrin-activating antibody
and tail mutationsRosetti et al., 2015, Cell Reports 10, 1655–1664
March 17, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.02.037Authors
Florencia Rosetti, Yunfeng Chen, ...,





Rosetti et al. show that the Mac-1 lupus
risk variant rs1143679 (R77H), located
outside the Mac-1 ligand binding aI-
domain, is primarily defective in binding
to ligand under flow. This correlates with
impaired 2D ligand affinity and catch-
bond formation.
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Leukocyte CD18 integrins increase their affinity for
ligand by transmitting allosteric signals to and from
their ligand-binding aI domain. Mechanical forces
induce allosteric changes that paradoxically slow
dissociation by increasing the integrin/ligand bond
lifetimes, referred to as catch bonds. Mac-1 formed
catch bonds with its ligands. However, a Mac-1
gene (ITGAM) coding variant (rs1143679, R77H),
which is located in the b-propeller domain and is
significantly associated with systemic lupus erythe-
matosus risk, exhibits a marked impairment in 2D
ligand affinity and affinity maturation under mechan-
ical force. Targeted mutations and activating anti-
bodies reveal that the failure in Mac-1 R77H allostery
is rescued by induction of cytoplasmic tail separation
and full integrin extension. These findings demon-
strate roles for R77, and the b-propeller in which it re-
sides, in force-induced allostery relay and integrin
bond stabilization. Defects in these processes may
have pathological consequences, as the Mac-1
R77H variant is associated with increased suscepti-
bility to lupus.
INTRODUCTION
Leukocyte integrins, which are composed of a unique a com-
plexed to a common b2 subunit, are amajor family of adhesive re-
ceptors. The regulation of their affinity for ligands is of key impor-
tance for cell adhesion and occurs through structural changes in
their extracellular domains. These allosteric changes are induced
upon cell activation by chemokines, ligand binding, and cyto-Cellplasmic regulators (Carman and Springer, 2003), and can also
be induced by mechanical forces that prolong the lifetime of re-
ceptor-ligand bonds (Chen et al., 2010; Choi et al., 2014; Fiore
et al., 2014; Kong et al., 2009), a counterintuitive phenomenon
called catch bonds (Sokurenko et al., 2008). Catch bonds may
allow leukocytes to roll stably and adhere firmly to the vessel
wall, and to migrate and form an immunological synapse with
antigen-presenting cells (Choi et al., 2014; Sokurenko et al.,
2008; Liu et al., 2014). Humans who lack b2 integrins (leukocyte
adhesion deficiency I [LADI]) or intracellular molecules required
for integrinactivation (LADIII) exhibit significantdefects inhostde-
fense, demonstrating the importance of integrins and their activa-
tion in immune cell function (Abram and Lowell, 2009). However,
to date, there is no evidence that alterations in integrin allostery or
catch bonds have pathological consequences in humans.
In two independent mouse models of systemic lupus erythe-
matosus (SLE), a multi-organ autoimmune disease (Tsokos,
2011), Mac-1 (aMb2) deficiency was shown to increase suscepti-
bility to developing nephritis (Kevil et al., 2004; Rosetti et al.,
2012). In humans, genome-wide association studies identified
variants of the ITGAM gene, which encodes the integrin alpha-M
(aM) chain, as risk factors for SLE (Hom et al., 2008). Despite
the identification of several Mac-1 SNPs, a strong risk effect
was mapped to rs1143679, which results in the substitution of
arginine for a histidine at position 77 (R77H) (Han et al., 2009).
Although the R77H variant compromises the adhesive functions
of Mac-1 to various extents (Fagerholm et al., 2013; Zhou et al.,
2013), the molecular mechanism underlying the effect of
this variant (which is located in the b-propeller outside of
the ligand-binding aI domain) on ligand binding is unclear.
Ligand binding by Mac-1 is contained within the aI domain, in-
serted in the b-propeller domain of the a subunit. The homolo-
gous aI and the b2-subunit bI domains bind Mg
2+ at their metal
ion-dependent adhesion sites (MIDAS), which coordinates an
invariant Glu or Asp shared by integrin ligands. Integrin activationReports 10, 1655–1664, March 17, 2015 ª2015 The Authors 1655
leads to cytoplasmic a/b tail separation and integrin extension.
The extension facilitates the sequential outward movement of
the hybrid domain, the downward shift of the bI a7 helix, and
the opening of the bI domain, which enhances bI-MIDAS binding
to the C terminus of the aI domain a7 helix invariant Glu, which
serves as an internal ligand. Internal ligand binding leads to a
downward shift of the aI a7 helix and thus activation of the aI
MIDAS for high-affinity binding of the external ligand (Carman
and Springer, 2003).
Here, we demonstrate that the Mac-1 R77H variant reduces
2D ligand-binding affinity and force-regulated dissociation of
receptor-ligand bonds (catch bonds). The latter is rescued by
mutations and an activating antibody distal to R77H that are
documented to induce integrin allosteric changes, indicating
that R77H regulates integrin allostery, which is needed to pro-
long the lifetime of adhesive bonds under shear flow. A reduction
in Mac-1’s binding affinity and bond stability may impact Mac-1
function and thus contribute to lupus susceptibility.
RESULTS
Neutrophils Expressing the Mac-1 R77H Variant Have
Defects in Neutrophil Adhesion under Hydrodynamic
Forces
The crystal structure of the sister integrin aXb2 (Sen et al., 2013),
which is 60% identical to Mac-1 (Yu et al., 2012), was used to
model Mac-1. Domains were further adjusted using the open
headpiece of aIIbb3 integrin (Xiao et al., 2004) to make an
extended-open Mac-1 integrin (Figure 1A). The R77H mutation
exists in the outer rim of the b-propeller, in close proximity to
the aI domain. The schematic shown in Figure 1A also contains
the location of binding sites of activation reporter, functional
blocking, and control antibodies used in our study.
To assess the functional repercussions of R77H, we evaluated
human neutrophils homozygous for the risk (R77H; rs1143679) or
non-risk variant. Surface expression of Mac-1 (Figure 1B), expo-
sure of the aM activation reporter epitope CBRM1/5 (Figure 1C),
neutrophil activation markers, and other surface molecules
(e.g., aLb2 and CD32) (Figure S1A) were similar upon stimulation
with the chemokine N-formylmethionyl-leucyl-phenylalanine
(fMLP). Thus, R77H has no effect on the expression and activa-
tion of Mac-1 on neutrophils, as previously reported (Zhou
et al., 2013). Adhesion assays on complement iC3b-coated sur-
faces were done under static or shear flow conditions following
fMLP treatment. Neutrophil binding was significantly reduced
by Mac-1 blocking antibodies (Table S1), and neutrophils with
the R77H variant had no defects in binding under static condi-
tions (Figure 1D), spreading (Figure 1E), or phagocytosis (data
not shown). However, they exhibited a significant decrease in
ligand binding under shear flow (Figure 1F). They also displayed
a trend toward reduced velocity during random migration
induced by shear force (Figure 1G), a Mac-1 dependent function
(Phillipson et al., 2006) that, like adhesion under shear flow, re-
quires optimal integrin on- and off-rates. These results were
recapitulated with neutrophils from healthy volunteers treated
with functional blocking antibodies to the b-propeller domain in
which R77H resides. CBRN1/6, 3/4, and 1/32 partially affected
adhesion under static conditions but abrogated ligand binding1656 Cell Reports 10, 1655–1664, March 17, 2015 ª2015 The Authorunder shear flow, whereas CBRM1/20 (another b-propeller anti-
body) andCBR LFA1/7 (a control-binding antibody) had no effect
(Figures 1H and 1I; Table S1). All antibodies bound Mac-1 simi-
larly (Figure S1B). iC3b may also have binding sites in the b-pro-
peller (Yalamanchili et al., 2000). However, b-propeller blockade
prevented binding to both ICAM-1 and iC3b under flow (Table
S1), suggesting that our results were not due solely to direct inhi-
bition of iC3b binding to the b-propeller. Finally, both b-propeller
inhibition and an antibody to the aI domain hindered the migra-
tion velocity of neutrophils (Figure 1J).
Residue R77 and the b-Propeller Are Required for
Mechanical Force-Induced Adhesion in K562 Cells
Expressing Mac-1
We found that 90% of the neutrophil samples that were homozy-
gous for the R77H were also homozygous for two other SLE-
associated SNPs, rs1143683 and rs1143678, which are present
in the Calf-1 and cytoplasmic domain of ITGAM, respectively, as
reported by others (Zhou et al., 2013). To assess the R77H-spe-
cific contribution, we evaluated the human leukemic cell line
K562 stably expressing similar levels of aM
WTb2 or aM
R77Hb2 (Fig-
ure S2A) and K562 cells alone after they were treated with Mg2+/
EGTA or Mn2+ to directly activate integrins (Xiao et al., 2004).
Mac-1 activation, examined with activation-reporter antibodies,
was similar in both groups (Figure S2B). Under static conditions,
Mg2+/EGTA-activated aM
R77H cells had a significant defect in
binding to iC3b surfaces, but Mn2+-treated aM
WT and aM
R77H
cells bound equivalently (Figure 2A), the latter being consistent
with the comparable binding capacity observed in fMLP-stimu-
lated neutrophils from risk and non-risk variants (Figure 1D).
The differential requirement for R77H in the presence of Mn2+
versus Mg2+/EGTA in static assays may reflect the occupation
of all three bI-domain metal sites by Mn2+, which, coupled with
high ligand density, maximizes the on-rate and integrin avidity
and thus bypasses the need for R77. On the other hand, Mg2+/
EGTA blocks the occupancy and thus the negative regulatory
role of Ca2+ at the ADMIDAS (Xiong et al., 2003), which results
in less stable internal ligand binding and requires R77 for full in-
tegrin activation. Under shear flow, R77H had a defect in binding
ICAM-1 in the presence of Mg2+/EGTA at shear stresses of 0.19–
0.42 dynes/cm2, with the most significant difference observed at
0.38 dynes/cm2 (Figure S2C). Further analysis at this shear stress
revealed impaired binding of aM
R77H cells to iC3b or ICAM-1 in
the presence of either Mn2+ or Mg2+/EGTA (Figure 2B). In addi-
tion, although b-propeller antibodies only partially affected adhe-
sion under static conditions, they significantly abrogated ligand
binding under shear flow (Figures 2C, 2D, and S1C; Table S1).
The similarity of the results obtainedwith human neutrophils sug-
gests that R77H in the b-propeller is primarily responsible for the
observed adhesion defects in human neutrophils.
Separation of the a- and b-Subunit Cytoplasmic Tails,
but Not bI-Domain Activation, Rescues the Mac-1-R77H
Binding Defect under Flow
Mutations in the bI domain of aXb2 that increase its affinity for the
aI a7-helix internal ligand result in a greater population of aI
domain in the open conformation, and thus stabilize aXb2 in an
extended conformation with an open headpiece (Sen et al.,s
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Figure 1. Functional Effects of the ITGAM R77H Risk Variant in Human Neutrophils
(A) Model of aMb2 ectodomain. The R77 region (arrow) and epitopes for antibodies are indicated with color-coded spheres.
(A–G) Neutrophils from non-risk and risk-variant donors were treated with fMLP or vehicle control ().
(B andC) Surface expression of aM (B) and CBRM1/5 antibody binding (C) were examined by flow cytometry. Data are the fold induction relative to vehicle-treated
cells. Representative histograms are shown. n = 4.
(D) Adhesion of neutrophils to an iC3b-coated surface under static conditions. The dotted line indicates binding of cells to a surface with heat-inactivated serum
(H.I.). n = 4 experiments.
(E) Spreading of neutrophils on iC3b. The cell area was quantified and representative photographs of cells stained with phalloidin (red) and DAPI (blue) are shown.
Scale bar, 10 mm. n = 4.
(F) Adhesion of neutrophils to iC3b under shear flow (0.38 dynes/cm2) at the indicated time points. Results are presented as percent of adherent neutrophils
relative to the non-risk donor at 10 min. n = 7–8 per genotype.
(G) Crawling velocity of neutrophils over a plasma-coated surface. n = 4 per genotype.
(H–J) Neutrophils from healthy volunteers were treated with CBRN1/6, CBRN 3/4, or CBRM1/32 antibodies to block specific b-propeller regions; CBRM1/29 to
block the aI-domain; or CBR LFA1/7, a non-blocking antibody binding control. Cell adhesion under static (H) and shear flow (I) conditions, and crawling velocity (J)
were evaluated. n = 4–6.
Data are mean ± SEM. See also Figure S1 and Table S1.
n.s., no statistical significance; *p < 0.05, **p < 0.01, ***p < 0.001 between neutrophils from non- and risk variants, and neutrophils with non-blocking versus
blocking antibodies.2013). We tested K562 cells expressing aM
WT or aM
R77H coupled
to the b2 subunit with or without the activating mutations V124A
(Figure S3A) or L132A (data not shown) in adhesion assays





V124A adopted an extended-open
conformation in the absence of activating cations (Figure S3B),
as predicted (Sen et al., 2013). However, aM
R77H with b2
V124ACell(Figure 2E) or b2
L132A (data not shown) remained impaired in
ligand binding under flow. The small molecule Leukadherin-1
(LA-1) binds and activates the aI domain without inducing global
conformational changes (Faridi et al., 2013). Although LA-1 pre-
treatment enhanced adhesion of aM
WT-expressing cells (data
not shown) as previously described (Faridi et al., 2013), it did
not rescue the ability of aM
R77H to bind iC3b under flowReports 10, 1655–1664, March 17, 2015 ª2015 The Authors 1657
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Figure 2. Functional Effects of Mac-1 R77H in K562 Cells
K562 cells lacking b2 integrins (–) or stably expressing aM
WT or aM
R77H with b2 were evaluated under static or flow conditions for adhesion to iC3b or ICAM-1
following activation with Mn2+ or Mg2+/EGTA, respectively, unless otherwise indicated.
(A) Adhesion of aM
WT or aM
R77H cells to iC3b-coated surfaces under static conditions. Results are presented as percent of adherent cells relative to cells ex-
pressing aM
WT plus Mn2+. n = 6 experiments.
(B) Adhesion of aM
WT or aM
R77H cells to iC3b and ICAM-1 under shear flow (0.38 dynes/cm2) evaluated at the indicated time points. Results are presented as
percent of adherent cells relative to cells expressing aM
WT at 8 min. n = 3–4 independent experiments.
(C and D) Binding of aM
WT cells to ligand-coated surfaces following treatment with the indicated b-propeller antibodies (as in Figure 1) under static (C) or shear flow
(D) conditions. n = 3–4.





(F and G) Adhesion of aM
WT or aM
R77H cells pretreated with leukoadherin-1 (LA-1) or vehicle control (F) or CBR LFA1/2 or the control antibody, CBR LFA1/7 (G).
(H) Adhesion of cells expressing aM
WT or aM
R77H with or without a GFFKR deletion (D). n = 3 for (E)–(H).
n.s., no statistical significance; *p < 0.05, **p < 0.01, ***p < 0.001 between aMWT and aMR77H (A–B), CBR LFA1/7 and other antibodies (D), aMWT/b2V124A and
aMR77H/b2V124A (E), aMWT and aMR77H with LA-1 (F), aMR77H plus CBR LFA 1/2 versus 1/7 (G), and aMR77H and aMR77HDGFFKR (H). Data are mean ±
SEM. See also Figures S2 and S3 and Table S1.(Figure 2F). Thus, neither an open, permissive bI domain nor
direct activation of the aI domain rescues R77H.
Mn2+ and chemokine treatments favor integrin extension, but
do not result in cytoplasmic tail separation (Kim et al., 2003;
O’Brien et al., 2012). We exploited the CBR LFA1/2 antibody,
which binds to the membrane proximal I-EGF-3 of the b2 subunit
(Lu et al., 2001) (see Figure 1A) and induces integrin extension
(Petruzzelli et al., 1995) and cytoplasmic tail separation in both
aMb2 (Lefort et al., 2009) and aLb2 (Kim et al., 2003). CBR
LFA1/2 rescued the binding defect of aM
R77H cells (Figure 2G).1658 Cell Reports 10, 1655–1664, March 17, 2015 ª2015 The AuthorTo validate this conclusion, we deleted the aM cytoplasmic tail
and thus the GFFKR (DGFFKR) sequence, the mutation of which
has been shown to result in tail separation and a fully extended,
active integrin in the absence of activating cations (Kanse et al.,
2004; Kim et al., 2003; Lu and Springer, 1997). Cells expressing
aM
R77HDGFFKR resumed the ability to bind ligand under shear flow
(Figure 2H). Unlike aLb2 (Lu and Springer, 1997),DGFFKR in aMb2
did not lead to constitutive extension and headpiece opening,
but Mg2+/EGTA orMn2+ induced similar conformational changes
in aM
R77HDGFFKR and aM
WTDGFFKR (Figures S3C and S3D). Thus,s
forcing the tail and lower-leg separation of the a and b subunits,
using both antibody and genetic approaches, restored adhesion
in R77H cells.
R77H Reduces the Binding Affinity of Mac-1 at Zero
Force by Decreasing Its On-Rate
To understand the effects of R77H on Mac-1’s ligand-binding
kinetics, we used a biomembrane force probe (BFP) (Figure 3A)
tomeasure single-bond interactions betweenMac-1-expressing
cells and ICAM-1-bearing beads in the presence of Mg2+/EGTA
(Figure 3B). We analyzed the absence (Figure 3C, cyan) or pres-
ence (Figure 3C, magenta) of binding after a contact of given
duration to obtain the adhesion frequency, and, when binding
occurred, the lifetime of (most likely) a single bond under a
desired force (Figure 3C). The adhesion frequencies of aM
WT
cells (Figure 3D, magenta circle) with ICAM-1 were higher than
those of aM
R77H (Figure 3D, cyan square) over a range of contact
times, even though the aM
WT cells had lower Mac-1 surface
expression. An anti-aI-domain blocking antibody, CBRM1/29,
abrogated adhesion, and streptavidin-coated beads blocked
with bovine serum albumin (BSA) also showed rare adhesion
events, confirming Mac-1 and ICAM-1 specificity (Figure 3D).
The adhesion frequency versus contact time data were fit to
Equation 1 in Supplemental Experimental Procedures along
with the site densities mr and ml to evaluate the effective 2D af-
finities (Figure 3E) and stress-free off-rates (Figure 3F). R77H
significantly reduced Mac-1 binding affinity, but not the off-rate
(Figures 3E and 3F). Since affinity is the ratio of on-rate to off-
rate, this indicates that R77H reduced the binding affinity of
Mac-1 for ICAM-1 by reducing its on-rate. The lower affinity
and on-rate of aM
R77H versus aM
WT at zero force provides a plau-
sible explanation for the defect in static adhesion of aM
R77H cells
in the presence of Mg2+/EGTA (Figure 2A).
Mac-1 R77H Suppresses Allosteric Catch Bonds
The mechanical regulation of Mac-1/ICAM-1 dissociation was
quantified by the BFP. Zero-force bond lifetimes measured by
thermal fluctuation were short and distributed as straight lines
in semi-log survival frequency versus bond lifetime plots for
both aM
WT (Figure 3G) and aM
R77H (Figure 3I). Their calculated
off-rates were not significantly different (Figures 3G and 3I) and
were comparable to the values obtained in the adhesion fre-
quency assay (Figure 3F).
In contrast, the lifetimes of aMb2/ICAM-1 bonds at low forces
were distributed as two line segments in these semi-log plots,
revealing two subpopulations of bonds (Figure 3G). The first sub-
population had fast dissociating rates, with off-rates comparable
to the bonds at zero force. The second subpopulation had much
slower dissociating rates, which equaled the negative slopes of
the second line segments (Figure 3G). The slopes of the second
line segments were much steeper (i.e., higher off-rates) for
aM
R77H (Figures 3I and 3J) than for aM
WT (Figures 3G and 3H)
at matched forces (R5 pN). Similar force induction of the slow-
dissociating subpopulation of bonds has been observed for
aLb2/ICAM-1, which results in catch bonds (Chen et al., 2010;
Xiang et al., 2011).
To examine whether Mac-1 forms catch bonds with ICAM-1,
we plotted the bond lifetimes against force. For aM
WT, as forceCellincreased, the lifetime first increased, reached the maximum
at 12 pN, and then decreased, exhibiting a biphasic transition
from catch to slip (Figure 3K). In comparison, the catch-slip
trend of aM
R77H was suppressed: the sharp summit in aM
WT
transformed into a relatively flat plateau with a 1-fold drop in
amplitude, a leftward shift, and a marked shrinking of the catch
regime to%5 pN, and a downward shift at the higher forces slip
regime (Figure 3K). At 12 pN, where aMWT reached the highest
lifetime of 4 s, the aM
R77H bond with ICAM-1 was 3-fold shorter-
lived (1 s). Catch bonds were attributed to aMb2/ICAM-1 in-
teractions because the rare adhesions of streptavidin-coated
beads to aM
WT cells in the presence of BSA alone showed negli-
gible lifetimes under all forces (Figure S4A). Since under some
conditions BSA can bind Mac-1 (Yalamanchili et al., 2000),
polyvinylpyrrolidone (PVP) was used alternatively to block non-
specific binding, which yielded results similar to those obtained
with BSA (Figure S4A), again suggesting that the short-lived
bonds (Figures 3G–3J) do not stem from potential Mac-1/BSA
interactions.
Therefore, R77H suppresses catch bonds, thus impairing the
ability of cells to sustain their association with ICAM-1 under
forces, but does not impact bond stability under force-free con-
ditions. This is concordant with the adhesion assays, which
show that R77H primarily impairs ligand binding under flow.
Rescue of Catch Bonds in Mac-1 R77H by the Activating
Antibody CBR LFA1/2
CBR LFA1/2 treatment resulted in indistinguishable adhesion
frequency versus contact time curves for aM
WT and aM
R77H (Fig-
ure S4B), with increased 2D affinities and reduced zero-force
off-rates (Figures 3E and 3F) for both forms of Mac-1. Signifi-
cantly, this antibody induced sizable subpopulations of slow-
dissociating bonds with very long lifetimes over a wide range
of forces for both aM
WT (Figures S4E and S4F) and aM
R77H (Fig-
ures S4G and S4H). This rendered an enhanced catch bond for
aM
WT with longer lifetimes under all forces than was obtained
without the antibody (Figure 3L). The CBR LFA1/2 also
increased the aM
R77H bond lifetime and rescued the sharp
catch-slip biphasic trend (Figure 3L). Notably, the two lifetime
curves of aM
WT and aM
R77H overlapped under all forces, indi-
cating that the impairment of the mutation on off-rate was
completely overcome by CBR LFA1/2. The control antibody,
CBR LFA1/7, confirmed the specificity of the activating effect
of CBR LFA1/2 (Figure 3L).
Cytoplasmic Tail Separation Rescues the Catch Bond in
R77H, whereas Activation of the bI Domain Has Only a
Partial Effect
GFFKR deletion increased the 2D affinity and reduced the zero-
force off-rate for aM
WT, but not aM
R77H (Figures 3E, 3F, and S4C).
Nonetheless, aM
R77HDGFFKR rescued its impaired catch-slip
trend (Figures 3M and S4I–S4L). The resulting lifetime curve
overlapped well with those of CBR LFA1/2-activated cells (Fig-
ure 3L). This suggests a central role for cytoplasmic tail separa-
tion in transmitting allosteric signals within the a subunit for
catch-bond formation.
Another mutation, b2
V124A, which stabilizes the bI domain in an
active state that is more permissive for internal ligand bindingReports 10, 1655–1664, March 17, 2015 ª2015 The Authors 1659
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Figure 3. Characterization of Mac-1/ICAM-1 Binding Kinetics and Catch-Bond Formation by a BFP
(A) A micrograph of a BFP experiment is shown. A micropipette-aspirated RBC with an ICAM-1-coated probe bead attached to the apex (left) via biotin-
streptavidin interaction was aligned against a target Mac-1-expressing K562 cell held by an opposing micropipette (right).
(B) A sketch of the probe bead double covalently coated with recombinant ICAM-1 and streptavidin, and the K562 cell expressing Mac-1.
(C) Superposition of force traces of two BFP contact cycles without (cyan) and with (magenta) an adhesion event. Without binding, the retraction curve returns to
zero force upon target cell retraction. A contact cycle with adhesion, held at 10 pN, renders a lifetime until dissociation.
(D) Adhesion frequency-versus-contact time plot of the indicated cell lines. The site densities of Mac-1 (mr) and ICAM-1 (ml, 80 mm
2) are marked along each
curve. The binding frequencies of aM
WT/ICAM-1 with either CBRM1/29 antibody (open black triangle) or streptavidin-coated beads (SA, open brown circle) at 1 s
contact are shown.
(E and F) Effective 2D affinity (AcKa, E) and off-rate (koff, F) of each Mac-1/ICAM-1 pair, calculated from fitting Equation 1 in Supplemental Experimental Pro-
cedures to the adhesion frequency data.
(G–J) Semi-log survival frequency versus bond lifetime plots of aM
WT (G and H) and aM
R77H (I and J) cells dissociating from the ICAM-1 bead under 0–12 pN (G
and I) or >12 pN (H and J) forces. Survival frequency is calculated as the fraction of the binding events with a lifetime longer than a certain value t (sec).
(K–N) Plots of mean ± SEM bond lifetime versus force of aM
WT and aM
R77H cells dissociating from ICAM-1 beads in the absence (K) or presence (L) of CBR LFA1/2
or CBR LFA1/7 control antibody, or with a GFFKR deletion (M) or a b2
V124 mutation (N).
Data are mean ± SEM. See also Figure S4.(Sen et al., 2013), resulted in a higher effective 2D affinity in cells
expressing aM
WT (Figures 3E and S4D). b2
V124A expression with
aM
R77H not only rescued the deficiency of aM
R77H in the 2D affin-1660 Cell Reports 10, 1655–1664, March 17, 2015 ª2015 The Authority but also increased it to a level higher than aM
WTb2
WT (Fig-
ure 3E). The b2
V124A had minor effects on the off-rate of aM
R77H
and aM
WT (Figures 3F and S4D), indicating that the affinitys
increase resulted solely from the change in on-rate. Under force,
V124A did not increase the peak lifetime of aM
R77H (Figures 3N
and S4M–S4P). However, the force regime of the ‘‘catch’’ phase
was broadened to be similar to aM
WT, indicating a partial rescue
of the catch bond (Figure 3N). This partial rescue was not
detected in the shear flow assay (Figure 2E), likely because off-
rates and ligand densities also contribute to ligand-integrin inter-
action in this assay.
DISCUSSION
We demonstrate that the SLE-associated variant R77H in the
Mac-1 aM subunit (ITGAM) alters Mac-1’s 2D affinity and its abil-
ity to form catch bonds, a counterintuitive strengthening of re-
ceptor-ligand bonds under mechanical forces. The latter pro-
vides a compelling explanation for the marked defect in this
variant’s ability to bind ligand, primarily under flow conditions.
Thus, R77H does not lead to an overall reduction in Mac-1 ligand
binding. Rather, R77 plays a regulatory role, which is consistent
with the fact that it is outside the ligand-binding aI domain. The
rescue of the R77H bond lifetime under force with activating an-
tibodies or mutations that have been documented to induce allo-
stery identifies a specific role for R77 in force-induced Mac-1
bond stability, a finding that adds another level of complexity
to the regulation of integrin function. Moreover, the phenocopy
of R77H with b-propeller antibodies indicates new roles for
R77 and the domain in which it resides in integrin allostery trans-
mission, which is of interest because the b subunit has primarily
been reported to transmit the conformational changes associ-
ated with ligand binding (Schu¨rpf and Springer, 2011).
To explain the allosteric modulation of catch bonds by R77H,
we propose amodel based on the force balance within the integ-
rin and the interplay of two catch bonds (Figure 4). The force bal-
ance is between the total force, F, applied to the aI domain by
ICAM-1, and two component forces, Fa and Fb, supported by
the integrin a and b subunits, respectively (Figures 4C–4H). Fa
transmits through the aI domain N terminus into the b-propeller
domain near the lesion at R77, whereas Fb transmits through
the aI domain a7 helix into the bI domain via the internal ligand
(e.g., Figure 4C). The two catch bonds are (1) the external catch
bond between the aI domain and ligand elicited by the total F,
and (2) the internal catch bond between the aI and bI domains
via the internal ligand elicited by component force Fb. These
two catch bonds are coupled, as the external catch bond re-
quires pulling of the aI domain a7 helix by the internal catch
bond (Chen et al., 2010). The R77Hmutation tilts the balance be-
tween the total force and the two component forces, resulting in
a decrease in Fa and an increase in Fb (Figures 4C and 4D). This
speeds up the increase of Fb with increasing F and results in an
accelerated pulling of the aI domain a7 helix by Fb at still small F.
This manifests as an early rise of the Mac-1/ligand catch bond
with a longer lifetime for R77H than for the wild-type (WT) at 5
pN. A further increase in F (F > 7 pN) transitions the aI-bI interdo-
main interaction to a slip bond that is less able to pull on the aI
domain a7 helix to elicit the external catch bond with ligand,
thus resulting in an earlier transition from the catch- to slip-
bond regime for R77H compared with WT (Figures 4C and 4D).
This explains the compression of the force range F of the Mac-Cell1/ligand catch bond from 0–12 pN for aM
WT to 0–5 pN for
aM
R77H (Figure 3K).
CBR LFA1/2 maximally activates Mac-1 by inducing full integ-
rin extension. Separation of the a and b tails occurs upon binding
of this antibody or deletion of the a-subunit GFFKR sequence,
both of which augmented the catch bond in aM
R77H by force
redistribution (Figures 4E and 4F). The Mac-1 aI domain exists
in an equilibrium between closed/inactive and open/active
states (Figures 4A–4C), transiently coupling the binding of the
external ligand to the binding of its internal ligand to the bI
domain. A catch bondwith ligand requires Fb to pull on the a7 he-
lix to activate the aI domain. We propose that cytoplasmic tail
separation swings out the hybrid domain to activate the bI
domain for binding of the internal ligand. The strengthened inter-
nal catch bond enables the allosteric relay between aI and bI do-
mains, and supports a higher Fb to amplify (for WT) and rescue
(for R77H) the Mac-1/ligand catch bond (Figures 4E and 4F).
The V124A mutation stabilizes the bI domain in an active state
that is more permissive for internal ligand binding (Sen et al.,
2013). Thus, the mechanism for the V124A mutation to broaden
the force range of the aI-bI interdomain catch bond and to right-
shift the lifetime-versus-force curve of the Mac-1/ligand catch
bond may be qualitatively similar to but quantitatively less effec-
tive than that of the CBR LFA1/2 and DGFFKR for both aM
WT and
aM
R77H (Figures 4G and 4H). The suppressed Mac-1/ligand
catch bond in R77H resembles (albeit less dramatically) the
altered lifetime-versus-force curve of aLb2’s bond with ICAM-1
in the presence of XVA143 (Chen et al., 2010), a small-molecule
antagonist that binds to the internal ligand-binding site on the bI
domain and blocks the conformation signal relay between the aI
and bI subunits (Shimaoka et al., 2003). How R77Hmay structur-
ally affect the aI and bI interdomain communication required for
catch bonds requires further study.
The ITGAM-R77H variant is a common allele in healthy popu-
lations (10%). In non-autoimmune conditions, the influence of
this variant may beminor due to the existence ofmany regulatory
checkpoints. However, in SLE, where dysfunction of several as-
pects of the immune response occurs simultaneously, the R77H
variant might impact disease. The possibility that the ITGAM
variant R77H in linkage disequilibrium with a true causative mu-
tation is responsible for the observed phenotypes is unlikely, as
the defects observed in neutrophils expressing R77H, as well
as other SNPs, were similar to those observed in a cell line with
R77H alone. How would compromised Mac-1 2D affinity for
ligand and catch-bond formation, as observed in the R77H
variant, increase SLE susceptibility? In addition to its pro-inflam-
matory roles, Mac-1 has immunosuppressive functions and in-
hibits the signaling of immune cell receptors (Fagerholm et al.,
2013) that have been implicated in SLE pathogenesis (Tsokos,
2011). The precise mechanisms through which Mac-1 exerts its
downmodulatory effects remain to be determined; however, ac-
cording to a concept currently being developed in other systems,
monovalent and low avidity ligation of a receptor leads to inhibi-
tory signaling, whereas multivalent ligation promotes activating
signals (Blank et al., 2009; Ivashkiv, 2011). Thus, we propose
that a reduction in Mac-1 2D ligand affinity in the absence of
high-valency ligand may prevent Mac-1’s inhibitory function.





Figure 4. Model of How R77H Affects Ligand Binding and Catch-Bond Formation by Mac-1
(A) Inactive, bent Mac-1 with a closed headpiece. The aI domain is in the inactive conformation, with the a7 helix in the up position and the MIDAS in the closed
conformation.
(B) Mac-1 extension induced by inside-out signaling (fMLP) or activating metal ions.
(C–H) Mac-1 under a lower (5 pN; C, E, and G) or higher (12 pN; D, F, and H) stretching force following ligand binding. The blue dotted line for CD18 in (C), (D), (G),
and (H) depicts the cytoplasmic tail in a clasped (as in B) or unclasped position. Force (F) applied by the ligand and the component forces from the aI-domain
MIDAS to the b-propeller (Fa) or the bI (Fb) domain are black for WT and red for R77H. R77H perturbs the force distribution so that more force is transmitted to the
bI domain and induces a premature catch bond at lower force (C), while at the higher force Fb exceeds the optimal value for aI- and bI-domain interaction and
results in a weaker binding capacity (D). Forced ectodomain extension and tail separation by CBR LFA1/2 antibody or deletion of the regulatory GFFKR of the a
subunit restores the force redistribution in R77H and hence rescues R77H by swinging out the hybrid domain to activate the bI domain and strengthen the aI-bI
interdomain catch bond to prolong the bond lifetime (E and F). The V124A mutation (#) moves the bI domain into a more activated state, resulting in more stable
internal ligand binding (green arrow). This partially rescues the R77H catch-bond defect (H), but to a lesser extent, and hence does not fix the perturbed force
distribution in R77H (G).undermechanical force (catch bonds), in the absence of multiva-
lent Mac-1 ligand engagement, may compromise inhibitory
Mac-1 signaling. Mac-1 upregulation of FcgR functions is well
known (Jones and Brown, 1996), but in models of lupus, an auto-1662 Cell Reports 10, 1655–1664, March 17, 2015 ª2015 The Authorimmune disease characterized by high levels of immune com-
plexes (Tsokos, 2011), Mac-1 deficiency leads to a significant in-
crease in glomerular neutrophil accumulation and lupus nephritis
(Kevil et al., 2004; Rosetti et al., 2012). The immunoglobulin Gs
(IgG)/immune complex receptor FcgRIIA mediates neutrophil
adhesion to intravascular deposited soluble IgG-immune com-
plexes (Tsuboi et al., 2008), which is enhanced by Mac-1 defi-
ciency (Rosetti et al., 2012). During FcgRIIA-mediated neutrophil
interactions with intravascular immune complexes, a defect in
bond stability between Mac-1 R77H and ligand upon force ex-
erted by blood flow could impact Mac-1’s downregulatory func-
tion on FcgRIIA and thus augment neutrophil accumulation.
Allosteric catch bonds have been reported for several hemato-
poietic cell receptor/ligand pairs. Our data show that a Mac-1
variant that confers high risk for developing lupus alters the relay
of allosteric signals required for catch bonds, suggesting that
elimination of catch bondsmay have pathological consequences.
EXPERIMENTAL PROCEDURES
Human Neutrophils, Lentiviral Constructs, and Generation of K562
Cell Lines
Genotyped human blood samples from ITGAM non-risk or risk variant (R77H)-
carrying donors were provided by the Genotype and Phenotype Registry, a
service of the Tissue Donation Program at The Feinstein Institute for Medical
Research (Manhasset, NY). b-propeller antibodies were used on neutrophils
from the blood of healthy volunteers under approved protocols (Brigham
and Women’s Hospital IRB). R77H and the GFFKR mutant (which was gener-
ated by including a stop codon before the GFFKR sequence) were generated
in human aM by PCR. b2
V124A and b2
L132A cDNA constructs were generated as
previously described (Sen et al., 2013). All constructs were cloned into lentiviral
plasmids (see Supplemental Experimental Procedures). K562 cells, which lack
endogenous aM and b2, were transduced with lentiviruses and sorted for pos-
itive-expressing cells. Multiple clones expressing similar surface levels ofMac-
1 were used in functional assays.
Static and Shear Flow Adhesion Assays
Integrin Activation
For Mg2+/EGTA-induced activation, K652 cells were washed with Hank’s
balanced salt solution (HBSS) without Ca2+ and Mg2+ (Lonza) with 5 mM
EDTA, washed again with HBSS, and resuspended in HBSS plus Mg2+/
EGTA (2 mM of each). For Mn2+-induced activation, K562 cells were washed
in HEPES plus 2 mM EGTA and 0.5 mM MnCl2, and resuspended in HEPES/
1 mM MnCl2. Neutrophils were activated with 500 nM fMLP in PBS plus
2 mM Ca2+ and Mg2+.
For details regarding ligand coating, see Supplemental Experimental
Procedures.
Static Adhesion Assays
Cells were labeled with carboxyfluorescein succinimidyl ester (CFSE; Molecu-
lar Probes, Invitrogen) and placed on ligand-coated surfaces plus activating
stimuli, and the percentage of adherent cells relative to aM
WT cells treated
with Mn2+ was calculated. For blocking experiments using the anti-b-propeller
antibodies, the percent inhibition relative to CBR LFA1/7 control was
calculated.
Shear Flow Adhesion Assay
Cells were perfused through a flow chamber at 1 dynes/cm2 for a min. Shear
flow was then decreased to 0.19–0.67 dynes/cm2 and the number of cells that
accumulated in four different fields after 2 min was calculated. Further details
are provided in Supplemental Experimental Procedures.
Spreading and Crawling Assay
For details regarding the spreading and crawling assay, see Supplemental
Experimental Procedures.
BFP
Details regarding the BFP have been previously described (Chen et al., 2008b).
Details regarding RBC and bead preparation and BFP analysis are provided in
Supplemental Experimental Procedures.
Adhesion Frequency Assay
An adhesion frequency assay reports the 2D binding kinetics between the re-
ceptor and ligand. For details, see Supplemental Experimental Procedures.CellThermal Fluctuation Assay
A thermal fluctuation assay was used for lifetime measurements under zero
force (Chen et al., 2008a, 2010). The ICAM-1 coating densities of the beads
were adjusted to achieve %20% adhesion frequency as required for single-
bond adhesion events. Details are provided in Supplemental Experimental
Procedures.
Force-Clamp Assay
A force-clamp assay was used to measure bond lifetimes under a constant
force as previously described (Chen et al., 2010). Details are provided in Sup-
plemental Experimental Procedures.
Lifetime Analysis
Lifetimes were categorized into bins of successive force ranges, each with a
width of 5 pN. The average lifetime in each force bin was collected to plot
the lifetime curve as a function of the clamping force.
Statistical Analysis
All data are mean ± SEM. The statistical significance of the differences was
determined by Student’s t test. For group analysis, two-way ANOVA was
used. If significant differenceswere shown, the data were subjected to Tukey’s
test for multiple comparisons, with p < 0.05 considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.02.037.
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